引用次数
引用: 5,761
H-指数: 46
I10-指数 : 80
出版物: 121
Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register
Antonio Ceriello , Giuseppe Lucisano , Francesco Prattichizzo , Björn Eliasson
Cardiovascular Diabetology 20 1 -10
17
2021
The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes
Antonio Ceriello , Giuseppe Lucisano , Francesco Prattichizzo , Rosalba La Grotta
The Lancet Regional Health–Europe 31
13
2023
Risk factor variability and cardiovascular risk among patients with diabetes: a nationwide observational study
Antonio Ceriello , Giuseppe Lucisano , Francesco Prattichizzo , Rosalba La Grotta
European Journal of Preventive Cardiology 30 ( 8) 719 -727
6
2023
Testing and Visualization of Associations in Three-Way Contingency Tables: A Study on Gender Gap in Patients with Type I Diabetes and Cardiovascular Complications
Rosaria Lombardo , Eric J Beh , Francesco Prattichizzo , Giuseppe Lucisano
Preprints
2024
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque
Raffaele Marfella , Francesco Prattichizzo , Celestino Sardu , Pasquale Paolisso
Atherosclerosis 378 117180 -117180
12
2023
Glycaemic management in diabetes: old and new approaches
Antonio Ceriello , Francesco Prattichizzo , Moshe Phillip , Irl B Hirsch
The lancet Diabetes & endocrinology 10 ( 1) 75 -84
79
2022
Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin
Rosalba La Grotta , Paola de Candia , Fabiola Olivieri , Giulia Matacchione
Cellular and Molecular Life Sciences 79 ( 5) 273 -273
62
2022
MiR-27b attenuates mitochondrial oxidative stress and inflammation in endothelial cells
Nunzia D'Onofrio , Francesco Prattichizzo , Elisa Martino , Camilla Anastasio
Redox Biology 62 102681 -102681
17
2023
Repurposing SGLT-2 inhibitors to target aging: available evidence and molecular mechanisms
Rosalba La Grotta , Chiara Frigé , Giulia Matacchione , Fabiola Olivieri
International Journal of Molecular Sciences 23 ( 20) 12325 -12325
17
2022
Effect of time and titer in convalescent plasma therapy for COVID-19
Paola de Candia , Francesco Prattichizzo , Silvia Garavelli , Rosalba La Grotta
IScience 24 ( 8)
16
2021
Teneligliptin enhances the beneficial effects of GLP-1 in endothelial cells exposed to hyperglycemic conditions
Valeria De Nigris , Francesco Prattichizzo , Elettra Mancuso , Rosangela Spiga
Oncotarget 9 ( 10) 8898 -8898
16
2018
Effect of hyperglycemia on COVID-19 outcomes: vaccination efficacy, disease severity, and molecular mechanisms
Celestino Sardu , Raffaele Marfella , Francesco Prattichizzo , Rosalba La Grotta
Journal of clinical medicine 11 ( 6) 1564 -1564
14
2022
Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists
Puja Ghosh , Rosaria Anna Fontanella , Lucia Scisciola , Ada Pesapane
Theranostics 13 ( 14) 4872 -4872
8
2023
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes
Raffaele Marfella , Francesco Prattichizzo , Celestino Sardu , Pier Francesco Rambaldi
Cardiovascular Diabetology 23 ( 1) 10 -10
6
2024
Is time ready for combination therapy at diagnosis of type 2 diabetes?
Francesco Prattichizzo , Antonio Ceriello
Diabetes/Metabolism Research and Reviews 37 ( 5) e3460 -e3460
5
2021
Weight variability and diabetes complications
Francesco Prattichizzo , Chiara Frigé , Rosalba La Grotta , Antonio Ceriello
Diabetes Research and Clinical Practice 199 110646 -110646
4
2023
Obesity and diabetes
Viral N Shah , Francesco Prattichizzo , Antonio Ceriello
Diabetes Technology & Therapeutics 25 ( S1) S -S
2
2023
Type 1 Diabetes and Associated Cardiovascular Damage: Contribution of Extracellular Vesicles in Tissue Crosstalk
Silvia Garavelli , Francesco Prattichizzo , Antonio Ceriello , Mario Galgani
Antioxidants & Redox Signaling 36 ( 10) 631 -651
1
2022
Obesity, NAFLD/NASH, and Diabetes
Francesco Prattichizzo , Antonio Ceriello , Viral N Shah
Diabetes Technology & Therapeutics 26 ( S1) S -S
2024
Feasibility of a Type 2 Diabetes Prevention Program at Nationwide Level in General Practice: A Pilot Study in Italy
Rosalba La Grotta , Valeria Pellegrini , Francesco Prattichizzo , Oriana Amata
Journal of Clinical Medicine 13 ( 4) 1127 -1127
2024